文献

J-GLOBAL ID：201602278758196730   整理番号：16A0642407

タウリンの血清レベルは肝硬変患者における潜在性肝性脳症の寛解と関連すると思われる

Serum level of taurine would be associated with the amelioration of minimal hepatic encephalopathy in cirrhotic patients

著者 (8件)： Saito Masaya (Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Hirano Hirotaka (Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Yano Yoshihiko (Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Yano Yoshihiko (Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Momose Kenji (Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Yoshida Masaru (Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Yoshida Masaru (Division of Metabolomics Research, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Azuma Takeshi (Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan)
資料名： Hepatology Research  (Hepatology Research)
巻： 46  号： 2  ページ： 215-224  発行年： 2016年02月 
JST資料番号： W1284A  ISSN： 1386-6346  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オーストラリア (AUS)  言語： 英語 (EN)

抄録/ポイント： 目的:潜在性肝性脳症(MHE)の肝硬変患者に対して,L-カル...

シソーラス用語： ヒト ,...
準シソーラス用語： *潜在性肝性脳症

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0642407&from=J-GLOBAL&jstjournalNo=W1284A") }}

著者キーワード (5件)： L-carnitine ,  liver cirrhosis ,  mitochondrial function ,  neurophysiological test ,  taurine

分類 (1件)： 消化器の疾患  (GH03000W)

物質索引 (2件)： L-カルニチン ,  タウリン

引用文献 (39件)：

• Zhou YQ, Chen SY, Jiang LD, et al. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol 2009; 24: 408-15.
• Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59.
• Malaguamera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007; 52: 3259-65.
• Wang JY, Zhang NP, Chi BR, et al. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol 2013; 19: 4984-91.
• Mina A, Moran S, Ortiz-Olvera N, Mera R, Uribe M. Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis. Hepatol Res 2014; 44: E92-9.

タイトルに関連する用語 (6件)： タウリン ,  血清レベル ,  肝硬変 ,  患者 ,  潜在性肝性脳症 ,  寛解